| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000035325 |
| Receipt No. | R000040250 |
| Official scientific title of the study | Elucidation of the efficacy and mechanism of resistance exercise in nonalcoholic fatty liver disease |
| Date of disclosure of the study information | 2018/12/21 |
| Last modified on | 2018/12/20 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Elucidation of the efficacy and mechanism of resistance exercise in nonalcoholic fatty liver disease | |
| Title of the study (Brief title) | Effect of resistance exercise on nonalcoholic fatty liver disease | |
| Region |
|
|
| Condition | ||
| Condition | Nonalchoholic fatty liver disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate the effects of resistance exercise on the disease parameters of nonalcoholic fatty liver disease |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Disease parameters of nonalcoholic fatty liver disease |
| Key secondary outcomes | Body composition
Liver fat content |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Resistance exercise | |
| Interventions/Control_2 | Education dietary restrictions and encourage to participate in regular physical activities | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Nonalcoholic fatty liver disease
|
|||
| Key exclusion criteria | 1 Patients with
Comorbidity with poor control Liver and Renal Failure Heart and lung disease Bone and Joint disease Acute infection 2 Patients determined to be inappropriate by physician 3 Patients who can not take written informed consent |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Atsushi Takahashi |
| Organization | Fukushima Medical University
|
| Division name | Gastroenterology |
| Address | 1 Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan |
| TEL | +81-24-547-1202 |
| junior@fmu.ac.jp | |
| Public contact | |
| Name of contact person | Atsushi Takahashi |
| Organization | Fukushima Medical University |
| Division name | Gastroenterology |
| Address | 1 Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan |
| TEL | +81-24-547-1202 |
| Homepage URL | |
| junior@fmu.ac.jp | |
| Sponsor | |
| Institute | Fukushima Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Fukushima Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | Compared to control group, fat-free mass and muscle mass significantly increased, whereas hepatic steatosis grade, mean insulin and ferritin levels, and the homeostasis model assessment-estimated insulin resistance index were significantly decreased in the exercise group. Compliance with the resistance exercise program did not significantly correlate with patient background characteristics such as age, sex, BMI and metabolic complications. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040250 |